|
| Samples | # | Genes functions | References |
|
| Pooled human normal and tumor samples | 1 |
*Cellular architecture, plasticity and movement | [33] |
| 26 human breast cancer cell lines and 5 nonmalignant immortalized cell lines | 2 |
*Signaling (axon guidance, ephrin receptor, integrin, and tight junctions), cytoskeleton organization, biogenesis, and cell signaling | [34] |
Breast | Nonmetastatic (67NR, 168FARN) and metastatic (4T07, 4T1) mouse primary tumors | 3 |
*Cellular morphology, and cellular movement | [35] |
| 168FARN, 4T07 and 4T1 mouse primary tumors | 3 |
*Cell growth, cell interactions, cell proliferation, cell migration, cell-to-cell signaling, cell death | [36] |
| 120 human breast tumors and 45 benign lesions | 4 | | [37] |
|
| 18 paired samples of human lung tumors and normal adjacent tissues | 3 | Remodeling of the cytoskeleton and cell movement | [38] |
Lung | 20 paired of human primary lung tumors and adjacent normal tissues | 3 |
*Tissue development, cellular growth and proliferation, tissue morphology, and immune response | [39] |
| 20 paired of human primary lung tumors and adjacent normal tissues | 5 | Cell adhesion, differentiation, proliferation, adhesion, migration, cytoskeleton, trafficking | [40] |
| 29 paired of human primary lung tumors and adjacent normal tissues | 5 | Cell signaling, cell proliferation, angiogenesis, cytoskeleton | [41] |
|
| 10 paired of human colon primary tumors and adjacent normal tissues | 3 |
*Cell motility and organization of the actin cytoskeleton, cell adhesion, and matrix organization | [42] |
Digestive tract | 20 human colon adenocarcinoma and 10 normal samples | 3 | Cancer-related, cytoskeleton, matrix organization, Wnt signaling | [43] |
| 12 samples of isolated cells from 10 patients | 3 | | [44] |
| 83 human colorectal tissue samples | 3 | | [45] |
|
| 14 pediatric medulloblastomas and 5 samples of normal cerebellum | 3 | Neuronal differentiation, cancer progression: cytoskeleton remodeling, cell morphology regulation, and cell-to-cell interaction | [46] |
Brain | 47 human neuroblastoma samples in stage 1 and stage 4 with normal or amplified MYCN copy number | 3 |
*Nervous system development, cell adhesion, synaptic transmission, and cytoskeleton organization and biogenesis | [47] |
| 24 human glioblastoma and 12 nontumor samples | 3 | Splicing, intracellular transport and cell migration, central nervous system, notch signaling, cell adhesion, apoptosis, cell growth | [48] |
| 26 human glioblastoma, 22 oligodendrogliomas and 6 nontumor samples | 3 | | [49] |
|